Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes.
Phase of Trial: Phase II
Latest Information Update: 25 Jul 2016
At a glance
- Drugs Exenatide (Primary)
- Indications Cardiovascular disorders; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 20 Jul 2016 Status changed from active, no longer recruiting to completed.
- 07 Mar 2016 Planned End Date changed from 1 Feb 2016 to 1 Jun 2016 as per ClinicalTrials.gov record.
- 05 Jan 2016 Planned End Date changed from 1 Dec 2015 to 1 Feb 2016 as reported by ClinicalTrials.gov.